JenaValve Technology Inc

Laguna Tech USA, Inc.Medical DeviceUnited States

77% matchPrivate

Laguna Tech USA, Inc. is a medical technology company that develops structural heart solutions, specifically focusing on transcatheter aortic valve systems. The company's flagship product, the ZETA Transcatheter Aortic Valve System, is an investigational device designed to treat both aortic regurgitation and aortic stenosis.

Jenscare Scientific Co., Ltd. operates as a medical technology enterprise dedicated to advancing interventional therapies for structural heart conditions within the People's Republic of China. Among its pipeline, the company features LuX-Valve, an investigational transcatheter tricuspid valve replacement (TTVR) system designed for patients suffering from severe tricuspid regurgitation who face elevated surgical risks. Additionally, Ken-Valve represents another key product candidate, a transcatheter aortic valve replacement (TAVR) aimed at addressing severe aortic regurgitation, often co-occurring with aortic stenosis. The applications of Jenscare's portfolio extend to a range of structural cardiac maladies, including disorders of the tricuspid, aortic, and mitral valves, as well as heart failure. Founded in 2011, the company maintains its principal place of business in Ningbo, People's Republic of China.

HighLife MedicalMedical DevicesFrance

72% match

HighLife Medical is a pre-commercial stage medical device company headquartered in Paris, France, with additional facilities in Irvine, California. The company develops trans-septal mitral valve replacement (TSMVR) technologies for treating structural heart disease.

enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.

Micro Interventional Devices, Inc. is a medical equipment manufacturing company developing novel solutions for structural heart disease treatments like mitral valve repair.

Innova Vascular, Inc.Medical DevicesUnited States

69% match

Innova Vascular, Inc. is a medical device company based in Irvine, California, engaged in the development of innovative minimally invasive vascular technologies such as the Laguna Thrombectomy System.